Ag-Bio Firm NewLeaf Symbiotics Raises $17M in Series B | GenomeWeb

NEW YORK (GenomeWeb) – Agricultural biotechnology firm NewLeaf Symbiotics today said that it has raised $17 million in Series B financing.

Proceeds will be used to accelerate the St. Louis-based firm's R&D program, move production from pilot to commercial scale, and launch its first biological products, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.